A high concentration of Fc-VFD treatment may cause a “cytokine chain reaction” in the TME because the Fc-VFD we created is still a kind of active VEGF dimer with small modifications and deletion defects and binds on VEGFR1/2 of endothelial and cancer cells. The gene discussed is VEGFA; the disease is cancer.